CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

Guifang Cai1, Anukanth Anumanthan, Julia A Brown

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature Immunology
|January 15, 2008
PubMed

Insights

CD160 acts as a negative regulator in CD4+ T cell activation. Its interaction with herpesvirus entry mediator (HVEM) modulates T cell responses, inhibiting activation when HVEM is engaged by CD160 or BTLA.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • CD160 is a GPI-anchored immunoglobulin superfamily member found on lymphocytes.
  • Its role in T cell activation, particularly in CD4+ T cells, requires further elucidation.

Purpose of the Study:

  • To investigate the function of CD160 in human CD4+ T cell activation.
  • To identify ligands for CD160 and elucidate their role in T cell signaling.

Main Methods:

  • Flow cytometry to assess CD160 expression.
  • Monoclonal antibody crosslinking to study CD160 function.
  • Co-culture assays with HVEM-transfected cells.
  • Genetic manipulation of HVEM (deletion of cysteine-rich domain 1).

Main Results:

  • CD160 expression increases upon human CD4+ T cell activation.
  • Crosslinking CD160 inhibits CD3/CD28-mediated T cell activation.
  • Herpesvirus entry mediator (HVEM) is a CD160 ligand, acting as a bidirectional switch for T cell activation.
  • HVEM-mediated inhibition of CD4+ T cell activation depends on CD160 and BTLA.

Conclusions:

  • CD160 functions as a negative regulator of CD4+ T cell activation.
  • The CD160-HVEM interaction is critical for modulating T cell responses.
  • HVEM's interaction with CD160 and BTLA dictates the outcome of T cell activation.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...